@acumpstey.bsky.social & @katy-skier.bsky.social speak with Denise Veelo & @berndsaugel.bsky.social about 2 @jama.com blood-pressure trials published on the same day - the PRETREAT & IMPROVE trials
They conclude routine targeting >MAP 65 is not broadly supported
www.topmedtalk.com/podcasts/eur...
